Dudley & Shanley Inc. decreased its position in AMETEK, Inc. (NYSE:AME – Free Report) by 8.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 127,243 shares of the technology company’s stock after selling 12,488 shares during the period. AMETEK comprises approximately 5.0% of Dudley & Shanley Inc.’s portfolio, making the stock its 4th biggest holding. Dudley & Shanley Inc. owned about 0.06% of AMETEK worth $31,522,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AME. Root Financial Partners LLC boosted its holdings in shares of AMETEK by 18.3% during the first quarter. Root Financial Partners LLC now owns 323 shares of the technology company’s stock worth $69,000 after purchasing an additional 50 shares during the period. Advocacy Wealth Management LLC lifted its holdings in AMETEK by 1.0% in the 2nd quarter. Advocacy Wealth Management LLC now owns 5,422 shares of the technology company’s stock worth $1,312,000 after buying an additional 52 shares during the period. Drucker Wealth 3.0 LLC grew its position in shares of AMETEK by 4.7% in the 1st quarter. Drucker Wealth 3.0 LLC now owns 1,187 shares of the technology company’s stock worth $255,000 after buying an additional 53 shares during the last quarter. Claret Asset Management Corp grew its position in shares of AMETEK by 4.0% in the 4th quarter. Claret Asset Management Corp now owns 1,585 shares of the technology company’s stock worth $325,000 after buying an additional 61 shares during the last quarter. Finally, Earned Wealth Advisors LLC increased its stake in shares of AMETEK by 5.9% during the first quarter. Earned Wealth Advisors LLC now owns 1,209 shares of the technology company’s stock valued at $259,000 after buying an additional 67 shares during the period. 87.43% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several brokerages have commented on AME. Truist Financial upped their price objective on shares of AMETEK from $303.00 to $316.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Royal Bank Of Canada boosted their price target on shares of AMETEK from $260.00 to $291.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Weiss Ratings upgraded shares of AMETEK from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, August 11th. Robert W. Baird lifted their price objective on AMETEK from $275.00 to $280.00 and gave the company a “neutral” rating in a research report on Monday. Finally, Seaport Research Partners reiterated a “buy” rating and set a $290.00 target price on shares of AMETEK in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $267.00.
AMETEK Stock Up 1.1%
Shares of AME traded up $2.77 during mid-day trading on Tuesday, reaching $254.69. The company had a trading volume of 222,781 shares, compared to its average volume of 1,305,754. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.76 and a current ratio of 1.21. The company has a market capitalization of $58.38 billion, a price-to-earnings ratio of 37.21, a price-to-earnings-growth ratio of 2.38 and a beta of 0.96. The firm has a 50-day moving average price of $244.05 and a 200 day moving average price of $234.58. AMETEK, Inc. has a 52 week low of $179.24 and a 52 week high of $261.16.
AMETEK (NYSE:AME – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The technology company reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.10. AMETEK had a return on equity of 16.93% and a net margin of 20.04%.The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $1.95 billion. During the same quarter in the previous year, the business earned $1.78 earnings per share. The firm’s quarterly revenue was up 15.0% compared to the same quarter last year. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. On average, sell-side analysts forecast that AMETEK, Inc. will post 8.42 EPS for the current year.
AMETEK Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Tuesday, September 15th. AMETEK’s dividend payout ratio is currently 19.88%.
Insider Activity at AMETEK
In related news, insider David Hermance sold 6,608 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $254.00, for a total value of $1,678,432.00. Following the completion of the transaction, the insider directly owned 42,509 shares in the company, valued at $10,797,286. The trade was a 13.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.54% of the stock is currently owned by insiders.
AMETEK Company Profile
AMETEK, Inc (NYSE: AME) is a global manufacturer of industrial technology products. The company develops and produces electronic instruments and electromechanical devices used in process, industrial, aerospace, power, energy, and other specialized markets.
AMETEK’s Electronic Instruments segment supplies products such as process and analytical instruments, measurement and testing equipment, power-quality monitoring systems, automation and control solutions, and equipment for aerospace and defense applications.
See Also
- Five stocks we like better than AMETEK
- InvenTrust’s Sell-Off Opens a Potential Entry Point
- Curaleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
- Why onsemi’s Synaptics Pivot Could Be a Game Changer
- AI Chip Demand Gives Linde a New Growth Catalyst
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
